These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16520774)

  • 1. Stops along the RAS pathway in human genetic disease.
    Bentires-Alj M; Kontaridis MI; Neel BG
    Nat Med; 2006 Mar; 12(3):283-5. PubMed ID: 16520774
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and molecular aspects of RAS related disorders.
    Denayer E; de Ravel T; Legius E
    J Med Genet; 2008 Nov; 45(11):695-703. PubMed ID: 18550698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of the ras pathway: an introduction.
    Viskochil DH
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):79-82. PubMed ID: 21495180
    [No Abstract]   [Full Text] [Related]  

  • 4. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndromes run together in the RAS pathway.
    Nat Genet; 2006 Mar; 38(3):267. PubMed ID: 16501550
    [No Abstract]   [Full Text] [Related]  

  • 6. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.
    Stevenson DA; Schill L; Schoyer L; Andresen BS; Bakker A; Bayrak-Toydemir P; Burkitt-Wright E; Chatfield K; Elefteriou F; Elgersma Y; Fisher MJ; Franz D; Gelb BD; Goriely A; Gripp KW; Hardan AY; Keppler-Noreuil KM; Kerr B; Korf B; Leoni C; McCormick F; Plotkin SR; Rauen KA; Reilly K; Roberts A; Sandler A; Siegel D; Walsh K; Widemann BC
    Am J Med Genet A; 2016 Aug; 170(8):1959-66. PubMed ID: 27155140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS and CSF3R mutations in severe congenital neutropenia.
    Germeshausen M; Kratz CP; Ballmaier M; Welte K
    Blood; 2009 Oct; 114(16):3504-5. PubMed ID: 19833857
    [No Abstract]   [Full Text] [Related]  

  • 9. RecQ helicases and topoisomerases: implications for genome stability in humans.
    Franchitto A
    Ital J Biochem; 2007 Jun; 56(2):115-21. PubMed ID: 17722652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRAS and the Costello syndrome.
    Rauen KA
    Clin Genet; 2007 Feb; 71(2):101-8. PubMed ID: 17250658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.
    Korf B; Ahmadian R; Allanson J; Aoki Y; Bakker A; Wright EB; Denger B; Elgersma Y; Gelb BD; Gripp KW; Kerr B; Kontaridis M; Lazaro C; Linardic C; Lozano R; MacRae CA; Messiaen L; Mulero-Navarro S; Neel B; Plotkin S; Rauen KA; Roberts A; Silva AJ; Sittampalam SG; Zhang C; Schoyer L
    Am J Med Genet A; 2015 Aug; 167A(8):1741-6. PubMed ID: 25900621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mTOR pathway and its role in human genetic diseases.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Mutat Res; 2008; 659(3):284-92. PubMed ID: 18598780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral Peters' anomaly in an infant with 22q11.2 deletion syndrome.
    Erdoğan MK; Utine GE; Alanay Y; Aktaş D
    Clin Dysmorphol; 2008 Oct; 17(4):289-90. PubMed ID: 18978663
    [No Abstract]   [Full Text] [Related]  

  • 14. RNA-binding proteins in human genetic disease.
    Lukong KE; Chang KW; Khandjian EW; Richard S
    Trends Genet; 2008 Aug; 24(8):416-25. PubMed ID: 18597886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction. Prelude to an anniversary for the RAS oncogene.
    Downward J
    Science; 2006 Oct; 314(5798):433-4. PubMed ID: 17053139
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical target promiscuity: lessons from ras molecular trials.
    Rengan R; Cengel KA; Hahn SM
    Cancer Metastasis Rev; 2008 Sep; 27(3):403-14. PubMed ID: 18461427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal phalangeal creases--a distinctive dysmorphic feature in disorders of the RAS signalling pathway?
    Ørstavik KH; Tangeraas T; Molven A; Prescott TE
    Eur J Med Genet; 2007; 50(2):155-8. PubMed ID: 17324647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
    Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
    Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders.
    Saida S
    Curr Treat Options Oncol; 2017 Jul; 18(7):41. PubMed ID: 28580501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome duplication is fundamental to life and health.
    MacNeill S
    Subcell Biochem; 2012; 62():v-vi. PubMed ID: 24479208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.